Andrew Aromando
Chief Business Officer at Oncolytics Biotech Inc (ONCY)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-17.9%
vs. S&P 500-28.0%
Beat the market0%
Paper profit on buys−$9K
Total bought / sold$25K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 13SEC | ONCYOncolytics Biotech Inc | Buy | 29,60055,100 held (+116%) | $0.86 | $25K | -34.9% |
- Buy
Chief Business Officer Andrew Aromando bought $25K of ONCY at $0.86 — first open-market purchase in our records; raises the stake by 116%.